chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feeling a little bit cold; Body Aches; conjunctivitis; Little bit of pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of CONJUNCTIVITIS (conjunctivitis), PAIN IN EXTREMITY (Little bit of pain in arm), FEELING COLD (Feeling a little bit cold) and MYALGIA (Body Aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (Little bit of pain in arm). On 20-Apr-2021, the patient experienced CONJUNCTIVITIS (conjunctivitis). On an unknown date, the patient experienced FEELING COLD (Feeling a little bit cold) and MYALGIA (Body Aches). On 18-Apr-2021, PAIN IN EXTREMITY (Little bit of pain in arm) had resolved. At the time of the report, CONJUNCTIVITIS (conjunctivitis), FEELING COLD (Feeling a little bit cold) and MYALGIA (Body Aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was unknown by the reporter. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-083006 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083006:
patient was given dose 1 of 0.5ml moderna but as it was administered part leaked out, after speaking to Moderna a 0.5ml dose was repeated immediately in the opposite arm as advised
This spontaneous report as received from a registered nurse refers to a patient of unknown gender and age. On 17-SEP-2014, the patient was vaccinated with an expired dose of MMR II lot # H015824, expiration ate: 24-AUG-2014, albumin status verified as HSA, 0.5 ml dose, subcutaneous (dose number not reported). No adverse effects were reported. No product quality complaint (PQC) involved. Additional information has been requested.
I examined patient 15 days post vaccination. Mom reported a hard knot and swelling the following day. Returned to our office at 2 weeks because the area is still discolored. Doesn't bother patient. She acts normal with full range of motion. Appears to me that subcutaneous tissue is gone resulting in dermis adhering to muscle of left thigh.
While walking to the he playground for duty, I fell to the left side. I passed out for an unknown amount of time. I injured both hands, left knee, left hip, left elbow, left shoulder and left side of my head. I was transported to the nearest ED where I was examined and x-rayed. I am very stiff and sore from the shot. I was unable to return to work on day one. I was limited on day two because of soreness and dizziness. I received chiropractic treatment on day two. I am continuing to ice and limit my activity.
Vaccine was taken on 1/2/2021 at 3:30 PM.  At 1:20 AM- developed chills, teeth chattering, could not get warm (no fever) 3:20 AM- woke up feeling hot- 101 F developed and headache 4AM- took aleve 6AM-temp 98.7. still a headache. woke up drenched in sweat 8:20AM: still pounding headache. temp 98.8
Has had 2 new knees put in/ Knee replacement; Rash on legs, back and arms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  An 82-year-old male patient received bnt162b2 (BNT162B2), on 29Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 82 years, in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for covid-19 immunization. The following information was reported: RASH (non-serious) with onset Sep2021, 2 days after the suspect product(s) administration, outcome "not recovered", described as "Rash on legs, back and arms"; KNEE ARTHROPLASTY (medically significant) with onset 2022, outcome "unknown", described as "Has had 2 new knees put in/ Knee replacement". The events "rash on legs, back and arms" required physician office visit. Therapeutic measures were taken as a result of rash. Clinical course: Patient was also prescribed Clobetasol Propionate USP 0.05% by dermatologist, but it did not help him. It made it worse.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300362819 same reporter/drug/event, different patient.;
A severe allergic skin reaction on Left arm from top of shoulder to half way around  and down the arm with intense itching, hot to touch. Treated with TRIAMCINOLONE ACETONIDE  OINTMENT USP, 0.1%  THE RASH RESOLVED IN 23 DAYS.
Severe dizziness & severe headache; don't feel comfortable walking around, even experiences while laying down; nauseated but no vomiting.
Itchy; Swollen; Red; 2 rash bites on her neck like mosquito bite; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), SWELLING (Swollen), ERYTHEMA (Red) and RASH (2 rash bites on her neck like mosquito bite) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy), SWELLING (Swollen), ERYTHEMA (Red) and RASH (2 rash bites on her neck like mosquito bite). At the time of the report, PRURITUS (Itchy), SWELLING (Swollen), ERYTHEMA (Red) and RASH (2 rash bites on her neck like mosquito bite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants were not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR received on 26-APR-2021 contains no new information.
Abdominal distention, diarrhea, fatigue, malaise lasting 10 days
SEEN ON 6/30/09 FOR 16 YEAR OLD WELL CHECK.  RECIEVED VARIVAX # 2.  ON 7/1/09 WOKE UP WITH RED, SWOLLEN TO TOUCH, WARM RIGHT ARM.  SEEN IN OUR OFFICE DIAGNOSED WITH CELLULITIS TO R ARM.  TREATED WITH KEFLEX.
One week after first Pfizer shot, had bad heart palpitations, thumping and very noticeable.  After two weeks, immediately before second shot, got slightly better. Went forward with second shot.   Still have mild heart palpitations ever since, but more like a flutter. But it has been continuous and it's now two months after. Also, extreme fatigue, shortness of breath and mild joint discomfort.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 17-DEC-2018, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number N034400 with expiration date in 10-MAY-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011434: US-009507513-1907USA001848: US-009507513-1907USA001847: US-009507513-1907USA001849: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
recvd vax 9SEP77&w/in hrs of vax pt devel a neurological illness described as sz disorder,convuls,encephalopathy,mental retardation,hypotonicity,coordination problems,ataxia,lethargy, develop delay;pt alleges events permanently disabling
Nine patients was administered the vaccine beyond the manufacturer date of expiry; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nine patients was administered the vaccine beyond the manufacturer date of expiry) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nine patients was administered the vaccine beyond the manufacturer date of expiry). On 14-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Nine patients was administered the vaccine beyond the manufacturer date of expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported. No Treatment medication reported. Reported that the date moved to refrigeration was on 14 September 2021 Use by date was on 31 August 2021
Severe Fatigue Medical records state fever, short of breath, tachycardic. msv
Fever of 101.3. For 4 days of fever, chills, vomiting, fatigue.
pt recvd vax; lab tests revealed anti-HBs 75, anti-HBc pos & anti-HBe pos; re-evaluation revealed anti-HBs neg; anti-HBc neg; anti-HBe neg;
Allergic reaction to polyethylene glycol when treated with mRNA 1273; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic reaction to polyethylene glycol when treated with mRNA 1273) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for Prophylactic vaccination.    Concurrent medical conditions included Drug allergy (Lidocaine) and Nonsmoker.   On 09-Dec-2021, the patient received dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic reaction to polyethylene glycol when treated with mRNA 1273). At the time of the report, ALLERGY TO VACCINE (Allergic reaction to polyethylene glycol when treated with mRNA 1273) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is non alcoholic and non drug user.  No concomitant medications reported by reporter No treatment medications provided by the reporter.  Patient received Janssen COVID-19 vaccine on 09-DEC-2021 and  on 10-DEC-2021 experienced dull stomach pain and upper abdominal pain with the outcome not recovered and not resolved with possible causality assessment given by reporter and Mfr. vaccine.
pt devel stiffness & bruising of rt leg on wednesday evening 21JAN98;this occurred @ the inj site, according to pt mom;pt walked w/a limp on the following day;no medical care was sought;
Patient received Pfizer booster dose < 5 months after her Pfizer dose #2 (10/15/2021). Patient is not immunocompromised, so she does not meet the minimum requirement of 5 months or greater.
In September I experienced a high fever (fluctuating 101-103), body aches, chills, and sore throat. I took an at home COVID test and was negative the day after symptoms started and again 36 hours later. However, I have been experiencing random mild headaches, sensitivity to hot and cold unlike before, and fatigue since I got over the illness, which was undecided - I was told it was likely a viral infection but not definitively.
Patient went to ER with local reaction to left arm from pneumovax 23 lot #0740R. Swelling, pain at site.
7/25--presently admitted 57y.o. year old male with past medical history significant for hypertension, hyperlipidemia, type 2 diabetes, obstructive sleep apnea, morbid obesity, psoriatic arthritis, and morbid obesity admitted for A. fib with RVR, NSTEMI, and newly diagnosed multivessel coronary artery disease.  Was eval by CT surgery found to be poor candidate for cardiac surgery but per chart review is willing to undergo high risk PCI. Patient incidentally tested positive for COVID-19 on 7/30/2022, cycle threshold was 19.1.  He is denied any shortness of breath or chest pain.  Overnight nursing note documented patient was snoring with oxygen saturation 82% breathing room air, upon awakening he quickly recovered to 95%. We have been asked for COVID-19 recommendations.  He was vaccinated with the Moderna vaccine in  9/2021 but has not been boosted. Initial encounter with patient found him sitting up at his bedside on his phone.  He is currently feeling well.  He is on room air only complains of his systemic psoriasis.  Specifically, he denies shortness of breath, chest pain, congestion, headache, sore throat, or any other symptoms.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 75-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 12-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: right deltoid, batch number: 250795, expiry date: 30-Apr-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805485 was crossed linked to original cases 201804863 due to same reporter.
The day after she got the shots she got hives that morning welts everywhere from head to toe and it continued on still till this day I've taken her to the doctors twice they first just gave her a steroid shot and the second time they gave her steroid medicine and zertec and Benadryl at night but this wot rash will not go away unless she continues the use of the steroids it's now leaving scars in spots where she has kept itching she has never had a reaction to anything before she's always been healthy!  I have tried everything to try n help it and it doesn't help in any way sometimes to make it worse. She has been way fussier than usual!
Information has been received from a certified medical assistant referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) (dose, route not provided, lot number # L037565, expiration date 29-SEP-2017 and lot number # reported as L048466, expiration date 02-DEC-2017). No adverse effects were reported. There was no product quality issue (PQC) involved. VARIVAX, L037565, exp. 29-SEP-2017; L048466, exp. 02-DEC-2017. Temperature: 14F; Time frame: 2 hours, 15 minutes; Was back in range? Yes' Was previous temperature excursion? No; Was call because of a data logger? No; This is one of several reports received from the same source. Additional information has been requested.
Arrhythmia (irregular heartbeat).  Patient spent 24 hours with a Holter monitor showing 17% extra/irregular beats. After that, he took medication, then spent another 24 hours with a Holter monitor, showing the extra beats were gone.
other vaccine same date vaccine date: 14Feb2021; headache; feeling nauseous; stomach queasy; chills; complete lethargy; feel very tired for most of the day; This is a spontaneous report from a contactable consumer (patient).   A 70-year-old non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in the left arm on 14Feb2021 as a single dose for COVID-19 immunization. Medical history included chronic obstructive pulmonary disease, thyroid disorder. The patient was allergic to penicillin. The patient did not have any other vaccine in 4 weeks. The patient did not have COVID prior to vaccination. The patient was not tested for CVID post vaccination. Concomitant medication included levothyroxine sodium (LEVOTHYROXIN), gabapentin (GABAPENTIN), atorvastatin (LIPITOR [ATORVASTATIN]) taken for an unspecified indication. It was reported that every few days the patient experienced for a short time, 1-2 hours, headache, feeling nauseous, stomach queasy, chills, complete lethargy. It resides with Tylenol. The patient then felt very tired for most of the day. The patient felt fine on the days in between. On 14Feb2021 the patient experienced headache, feeling nauseous, stomach queasy, chills, complete lethargy, feel very tired for most of the day, other vaccine same date vaccine date: 14Feb2021 (product use issue). The clinical outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Within 1-2 days after vaccination I developed cough and shortness of breath. After 1st and second vaccinations cough and shortness of breath resolved within 2 weeks. After third, cough not resolved after 1 month. Shortness of breath more pronounced.
Headache, body aches, fever of 100.6, fatigue. The area surrounding the injection site became red and swollen and slightly itchy to the touch similar to an allergic reaction to a bug bite. This was the first symptom I got. I can still move my arm but it hurts to touch the area where the red inflammation is. It's not directly on the injection site but slightly to the left of where I got the injection
I received my third Moderna dose on 8/26/2021 at about 3:30PM. Later that night between 11:00PM and midnight, I started to feel flu-like symptoms and developed a fever. I had very intense body aches, fever, nausea, headache, and extreme fatigue. The symptoms lasted for 2 days. My fatigue was so intense that I could barely even move myself to go to the bathroom (but I managed it). I took Tylenol to treat the symptoms, though it didn't help much. I called my physician's assistant on 8/27/2021 to let her know that I thought I might have COVID19. Since I am a post-transplant patient, she urged me to get tested as soon as possible, because if I tested positive, time was of the essence and I would need a monoclonal antibody transfusion. Thankfully, though, I ended up testing negative. I eventually got better afterwards.
Nausea; diarrhea; dizziness; fatigue; joint and muscle pain; joint and muscle pain; chills; sinus and ear congestion; sinus and ear congestion; runny nose; sneezing; cognitive blunting; injection site inflammation and pain; injection site inflammation and pain; cough; This is a spontaneous report from a contactable other HCP (patient). A 69-year-old non-pregnant female patient (consumer) received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EL9261; Expiration Date: 22Feb2021), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 14:00 (age 69-year-old at the time of vaccination) as DOSE 1, SINGLE for covid-19 immunisation. Facility type vaccine was in Hospital. The medical history included, Meiges disease; Seropositive RA; severe Osteoarthritis/4 joint replacements; ADHD; allergies and TIA (Transient ischaemic attack) all from an unknown date and unknown if ongoing. The patient had known allergies of Codeine; Bupropion; Lidocaine; and Cortisone preservatives. The concomitant medications included certolizumab pegol (CIMZIA); hydroxychloroquine sulfate (PLAQUENIL); Prednisone; acetylsalicylic acid (ASPIRIN); and venlafaxine hydrochloride (EffexorXR) all taken for an unspecified indication, start and stop date were not reported. The did not had covid prior vaccination and covid was not tested post vaccination. The patient did not receive any other vaccine in four weeks. The patient experienced nausea, diarrhoea, dizziness, fatigue, joint and muscle pain, chills, sinus and ear congestion, runny nose, sneezing, cognitive blunting, injection site inflammation and pain, cough all events on 22Feb2021 12:00 AM. The diagnosis were mod-severe and present 1-7 days post injection. No treatment was received for all the adverse events. The outcome of the events was reported as recovering.  No follow-up attempts are possible. No further information is expected.
My stomach felt queasy, winded, feeling out of it, and I was still tired after I woke up which was unusual.  I took an at home COVID-19 test and tested positive. I called my doctor and she prescribed me Paxlovid. On the 7th day I tested again and I was still positive for COVID-19. This morning me and my wife tested negative for the first time.
This is a spontaneous report from a contactable nurse via a sales representative. This nurse reported similar events for four patients. This is the second of four reports. A patient of unspecified age, ethnicity, and gender received PREVNAR 13 (Lot number: S43277, Expiration date: Sep2018), via an unspecified route of administration on an unspecified date as a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced redness, swelling, and a hard knot at the injection site on an unspecified date lasting for several days. There were also bumps and immunization stinging. It was reported that the onset was within the last 2 weeks with the most recent lot number. The nurse also reported administering the product with possible quality issue to the patient. Outcome of the events was unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2017400561 different patient; same product, similar events.